A neutralizing IL-11 antibody reduces vessel hyperplasia in a mouse carotid artery wire injury model

© 2021. The Author(s)..

Vascular restenosis remains a major problem in patients with coronary artery disease (CAD) and peripheral artery disease (PAD). Neointimal hyperplasia, defined by post-procedure proliferation and migration of vascular smooth muscle cells (VSMCs) is a key underlying pathology. Here we investigated the role of Interleukin 11 (IL-11) in a mouse model of injury-related plaque development. Apoe-/- mice were fed a hyperlipidaemic diet and subjected to carotid wire injury of the right carotid. Mice were injected with an anti-IL11 antibody (X203), IgG control antibody or buffer. We performed ultrasound analysis to assess vessel wall thickness and blood velocity. Using histology and immunofluorescence approaches, we determined the effects of IL-11 inhibition on VSMC and macrophages phenotypes and fibrosis. Treatment of mice with carotid wire injury using X203 significantly reduced post-endothelial injury vessel wall thickness, and injury-related plaque, when compared to control. Immunofluorescence staining of the injury-related plaque showed that X203 treatment did not reduce macrophage numbers, but reduced the number of VSMCs and lowered matrix metalloproteinase 2 (MMP2) levels and collagen content in comparison to control. X203 treatment was associated with a significant increase in smooth muscle protein 22α (SM22α) positive cells in injury-related plaque compared to control, suggesting preservation of the contractile VSMC phenotype. Interestingly, X203 also reduced the collagen content of uninjured carotid arteries as compared to IgG, showing an additional effect on hyperlipidemia-induced arterial remodeling in the absence of mechanical injury. Therapeutic inhibition of IL-11 reduced vessel wall thickness, attenuated neointimal hyperplasia, and has favorable effects on vascular remodeling following wire-induced endothelial injury. This suggests IL-11 inhibition as a potential novel therapeutic approach to reduce arterial stenosis following revascularization in CAD and PAD patients.

Medienart:

E-Artikel

Erscheinungsjahr:

2021

Erschienen:

2021

Enthalten in:

Zur Gesamtaufnahme - volume:11

Enthalten in:

Scientific reports - 11(2021), 1 vom: 19. Okt., Seite 20674

Sprache:

Englisch

Beteiligte Personen:

Schumacher, David [VerfasserIn]
Liehn, Elisa A [VerfasserIn]
Nilcham, Pakhwan [VerfasserIn]
Mayan, David Castaño [VerfasserIn]
Rattanasopa, Chutima [VerfasserIn]
Anand, Kaviya [VerfasserIn]
Crespo-Avilan, Gustavo E [VerfasserIn]
Hernandez-Resendiz, Sauri [VerfasserIn]
Singaraja, Roshni R [VerfasserIn]
Cook, Stuart A [VerfasserIn]
Hausenloy, Derek J [VerfasserIn]

Links:

Volltext

Themen:

9007-34-5
Antibodies, Neutralizing
Collagen
EC 3.4.24.24
Interleukin-11
Journal Article
Matrix Metalloproteinase 2
Research Support, Non-U.S. Gov't

Anmerkungen:

Date Completed 25.01.2022

Date Revised 23.02.2022

published: Electronic

Citation Status MEDLINE

doi:

10.1038/s41598-021-99880-y

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM33207482X